Aging lung:acute exacerbation chronic obstructive pulmonary disease:case report

Authors

  • H.Jaasminerjiit Kaur Centre of Excellence in Pharmaceutical Sciences, School of Pharmacy, KPJ Healthcare University College, Lot PT 17010, Persiaran Seriemas Utama, Kota Seriemas, 71800 Nilai, Negeri Sembilan, Malaysia
  • Shashidharan Menon Centre of Excellence in Pharmaceutical Sciences, School of Pharmacy, KPJ Healthcare University College, Lot PT 17010, Persiaran Seriemas Utama, Kota Seriemas, 71800 Nilai, Negeri Sembilan, Malaysia
  • Krupavaram.B Centre of Excellence in Pharmaceutical Sciences, School of Pharmacy, KPJ Healthcare University College, Lot PT 17010, Persiaran Seriemas Utama, Kota Seriemas, 71800 Nilai, Negeri Sembilan, Malaysia
  • Kogila A/P Subramaniama Centre of Excellence in Pharmaceutical Sciences, School of Pharmacy, KPJ Healthcare University College, Lot PT 17010, Persiaran Seriemas Utama, Kota Seriemas, 71800 Nilai, Negeri Sembilan, Malaysia
  • G.V.Nagaraju Faculty of Pharmaceutical Sciences, Jaipur National University, Rajasthan, India

DOI:

https://doi.org/10.47957/ijpda.v9i2.474

Keywords:

COPD, MDI, electrolyte imbalance

Abstract

A woman with aged 82 years old admitted to emergency hospital due to shortness of breath and chesty cough since last 3 days with underlying hypertension and chronic obstructive pulmonary disease. Patient’s physical examination revealed tachypnea with respiratory rate of 28 beats per minute and series of spirometry examination was performed to diagnosed with acute exacerbation of COPD (GOLD A). Medication such as SABA and SAAC metered-dose inhaler, corticosteroid, and intravenous potassium and sodium infusion were given to control the patient’s COPD condition as well as electrolyte imbalance issue. Follow up sessions and smoking cessation program also been arranged to improve and monitor the medical condition of the patient and to improve patient’s quality of life. Pharmacist intervention on counselling and education in inhaler spacer together with the MDI device with proper storage and cleaning direction should be given to the patient and care givers.

Downloads

Download data is not yet available.

References

Conti V, Corbi G, Manzo V, Pelaia G, Filippelli A, Vatrella A. Sirtuin 1 and aging theory for chronic obstructive pulmonary disease. Analytical Cellular Pathology. 2015;2015.

Chetty U, McLean G, Morrison D, Agur K, Guthrie B, Mercer SW. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care. British Journal of General Practice. 2017;67(658):e321-e8.

Jayadev A, Gill S. COPD in the elderly: The ageing lung. GM; 2017.

Bourbeau J, Bartlett S. Patient adherence in COPD. Thorax. 2008;63(9):831-8.

Korner P, Edwards A. THE IMMEDIATE?EFFECTS OF ACUTE HYPOXIA ON THE HEART RATE, ARTERIAL PRESSURE, CARDIAC OUTPUT AND VENTILATION OF THE UNANÆSTHETIZED RABBIT. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences: Translation and Integration. 1960;45(2):113-22.

Goldman L. schafer AI. Goldman’s Cecil medicine [Internet]. Philadelphia: Elsevier Health Sciences; 2012.

Lim TK, Chee CB, Chow P, Chua G, Eng SK, Goh SK, et al. Ministry of Health clinical practice guidelines: Chronic obstructive pulmonary disease. Singapore Med J. 2018;59(2):76-86.

Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine. 2007;176(6):532-55.

Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2008;5(4):513-8.

Roche N, Criner G, Vogelmeier C. GOLD Reports on Chronic Obstructive Pulmonary Disease (COPD): Evolutions, Revolutions and Controversies. 2019.

Davies L, Angus R, Calverley P. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. The Lancet. 1999;354(9177):456-60.

Schols A, Wesseling G, Kester A, De Vries G, Mostert R, Slangen J, et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. European Respiratory Journal. 2001;17(3):337-42.

Nouira S, Marghli S, Belghith M, Besbes L, Elatrous S, Abroug F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. The Lancet. 2001;358(9298):2020-5.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology Dialysis Transplantation. 2014;29(suppl_2):i1-i39.

Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocrine connections. 2018;7(4):R135-R46.

Preventive U. Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(8):551-5.

Published

2021-07-06
Statistics
42 Views | 23 Downloads
Citatons

How to Cite

Kaur, H., S. Menon, K. B, A. S. Kogila, and V. G. “Aging lung:acute Exacerbation Chronic Obstructive Pulmonary disease:Case Report”. International Journal of Pharmaceutics and Drug Analysis, vol. 9, no. 2, July 2021, pp. 137-42, doi:10.47957/ijpda.v9i2.474.

Issue

Section

Case Reports
Share |